K. Kralovicová

Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome

V. Krčméry, E. Oravcová, S. Špánik et al. · Journal of Antimicrobial Chemotherapy · 1998 · 101 citations · Full text

Pathology, Clinical Mycology, Antimicrobial Chemotherapy +19

Do Vancomycin Serum Levels Predict Failures of Vancomycin Therapy or Nephrotoxicity in Cancer Patients?

K. Kralovicová, S. Špánik, J. Halko et al. · Journal of Chemotherapy · 1997 · 39 citations

Fungemia in Cancer Patients Undergoing Chemotherapy Versus Surgery: Risk Factors, Etiology and Outcome

K. Kralovicová, S. Špánik, E. Oravcová et al. · Scandinavian Journal of Infectious Diseases · 1997 · 22 citations

Surgical Oncology, Chemotherapy Versus Surgery, Pathology +19

Analysis of 553 episodes of monomicrobial bacteraemia in cancer patients: any association between risk factors and outcome to particular pathogen?

S. Špánik, E. Kukučková, P. Pichňa et al. · Supportive Care in Cancer · 1997 · 21 citations

Antimicrobial Susceptibility, Monomicrobial Bacteraemia, Healthcare-associated Infection +9

Eight-Year Surveillance of Non-Albicans <i>Candida spp</i> . in an Oncology Department Prior to and After Fluconazole Had Been Introduced into Antifungal Prophylaxis

A. Kunová, J. Trupl, A. Demitrovicová et al. · Microbial Drug Resistance · 1997 · 14 citations